These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 26821286)
1. A novel compact mass detection platform for the open access (OA) environment in drug discovery and early development. Gao J; Ceglia SS; Jones MD; Simeone J; Antwerp JV; Zhang LK; Ross CW; Helmy R J Pharm Biomed Anal; 2016 Apr; 122():1-8. PubMed ID: 26821286 [TBL] [Abstract][Full Text] [Related]
2. Applications of the charged aerosol detector in compound management. Sinclair I; Charles I J Biomol Screen; 2009 Jun; 14(5):531-7. PubMed ID: 19483147 [TBL] [Abstract][Full Text] [Related]
3. Development of a high-speed, multiplexed sample-delivery instrument for LC-MS/MS bioanalysis. Janiszewski J; Schneider R; Kapinos B; West M; Funk C; Federico J; Umland J; Piotrowski M; Mitchell W; Zhang H; Zelesky V; Gobey J; Whalen K; Liston T; Troutman M Bioanalysis; 2012 May; 4(9):1039-56. PubMed ID: 22612685 [TBL] [Abstract][Full Text] [Related]
4. Integration of micro-fractionation, high-performance liquid chromatography-ultraviolet detector-charged aerosol detector-mass spectrometry analysis and cellular dynamic mass redistribution assay to accelerate alkaloid drug discovery. Wang R; Liu Y; Zhou H; Chen Y; Wang J; Zhang X; Yu R; Liang X J Chromatogr A; 2020 Apr; 1616():460779. PubMed ID: 31866135 [TBL] [Abstract][Full Text] [Related]
5. Automated open-access liquid chromatography high resolution mass spectrometry to support drug discovery projects. Fontana A; Iturrino L; Corens D; Crego AL J Pharm Biomed Anal; 2020 Jan; 178():112908. PubMed ID: 31610393 [TBL] [Abstract][Full Text] [Related]
6. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. Ramanathan R; Jemal M; Ramagiri S; Xia YQ; Humpreys WG; Olah T; Korfmacher WA J Mass Spectrom; 2011 Jun; 46(6):595-601. PubMed ID: 21630388 [TBL] [Abstract][Full Text] [Related]
7. Increasing high-throughput discovery bioanalysis using automated selected reaction monitoring compound optimization, ultra-high-pressure liquid chromatography, and single-step sample preparation workflows. Smalley J; Xin B; Olah TV Rapid Commun Mass Spectrom; 2009 Nov; 23(21):3457-64. PubMed ID: 19813283 [TBL] [Abstract][Full Text] [Related]
8. Investigating the human metabolism of acetaminophen using UPLC and exact mass oa-TOF MS. Johnson KA; Plumb R J Pharm Biomed Anal; 2005 Sep; 39(3-4):805-10. PubMed ID: 16054322 [TBL] [Abstract][Full Text] [Related]
9. Analysis of food polyphenols by ultra high-performance liquid chromatography coupled to mass spectrometry: an overview. Motilva MJ; Serra A; Macià A J Chromatogr A; 2013 May; 1292():66-82. PubMed ID: 23369748 [TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-mass spectrometry and related techniques for purity assessment in early drug discovery. Molina-Martin M; Marin A; Rivera-Sagredo A; Espada A J Sep Sci; 2005 Sep; 28(14):1742-50. PubMed ID: 16224969 [TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening. Tolonen A; Turpeinen M; Pelkonen O Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358 [TBL] [Abstract][Full Text] [Related]
12. Automated mass correction and data interpretation for protein open-access liquid chromatography-mass spectrometry. Wagner CD; Hall JT; White WL; Miller LA; Williams JD J Mass Spectrom; 2007 Feb; 42(2):139-49. PubMed ID: 17221927 [TBL] [Abstract][Full Text] [Related]
13. Fast log P determination by ultra-high-pressure liquid chromatography coupled with UV and mass spectrometry detections. Henchoz Y; Guillarme D; Martel S; Rudaz S; Veuthey JL; Carrupt PA Anal Bioanal Chem; 2009 Aug; 394(7):1919-30. PubMed ID: 19533106 [TBL] [Abstract][Full Text] [Related]
14. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Qi Y; Song Y; Gu H; Fan G; Chai Y Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920 [TBL] [Abstract][Full Text] [Related]
16. Principles and applications of LC-MS in new drug discovery. Korfmacher WA Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874 [TBL] [Abstract][Full Text] [Related]
17. The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry. Mallett DN; Ramírez-Molina C J Pharm Biomed Anal; 2009 Jan; 49(1):100-7. PubMed ID: 19019615 [TBL] [Abstract][Full Text] [Related]
18. High-throughput bioanalysis of bile acids and their conjugates using UHPLC coupled to HRMS. Ding J; Lund ET; Zulkoski J; Lindsay JP; McKenzie DL Bioanalysis; 2013 Oct; 5(20):2481-94. PubMed ID: 24138622 [TBL] [Abstract][Full Text] [Related]
19. Rapid identification of new minor chemical constituents from Smilacis Glabrae Rhizoma by combined use of UHPLC-Q-TOF-MS, preparative HPLC and UHPLC-SPE-NMR-MS techniques. Gu WY; Li N; Leung EL; Zhou H; Yao XJ; Liu L; Wu JL Phytochem Anal; 2015; 26(6):428-35. PubMed ID: 26183111 [TBL] [Abstract][Full Text] [Related]
20. Open-access liquid chromatography/mass spectrometry in a drug discovery environment. Mallis LM; Sarkahian AB; Kulishoff JM; Watts WL J Mass Spectrom; 2002 Sep; 37(9):889-96. PubMed ID: 12271431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]